To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

October 08, 2018

Today's Rundown

Featured Story

GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round

GlaxoSmithKline has helped Sitryx to a $30 million (€26 million) funding round. Newly formed British biotech Sitryx will use the money and its relationship with GSK to move immunometabolism assets toward human testing.

Top Stories

Menlo Therapeutics' serlopitant comes up short in chronic cough

Just six months after its lead drug flunked a phase 2 trial in atopic dermatitis, Menlo is reporting another fail—this time in chronic cough.

Phase 3 rare disease flop leaves Diurnal reeling

Diurnal’s Chronocort has failed to beat the control in a phase 3 congenital adrenal hyperplasia trial. The modified-release preparation of hydrocortisone was no better at controlling sex hormones than conventional glucocorticoid doses, sending Diurnal’s stock into a downward spiral.

Akcea sets off after Alnylam’s hATTR therapy in U.S., but with a handicap

Ionis spinout Akcea has its first FDA approval in the bag, getting a green light for rare disease hATTR drug Tegsedi, but it will be burdened with a black box warning as it chases rival Alnylam.

Xencor’s lead lupus antibody misses phase 2 endpoint

Topline results from a phase 2 study showed Xencor’s lead CD19-targeting antibody missed its primary endpoint in lupus, but the company described the data as a “positive trend” that still contained a “promising treatment effect” worthy of future study.

Lilly makes waves with next-gen diabetes drug, but GLP-1 rivals needn't panic: analysts

Last week, Eli Lilly unveiled positive data for a new diabetes drug with serious potential to disrupt the GLP-1 market. But its rivals don't need to hunker down, analysts said.

Enrollment Showcase

Online Graduate Programs Designed for Your Career

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.

Resources

[Whitepaper] Unlocking New Business Value in Life Sciences with Digital Technology

Collaborate in a digital world to improve patient outcomes.

[Whitepaper] Is Your In-House Strategy Ready For The Uncertainties Of Biologic Drug Development?

Read this whitepaper to learn more about two main areas where a drug developer can face significant obstacles during biologics development.

[Research] Linguistic and Cultural Considerations When Implementing a Global BYOD Study

Examine the linguistic and cultural considerations of global eCOA and BYOD.

[eBook] Healthcare and Life Sciences - Data Value Chain

Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data.

[Infographic] Flexible. Scalable. Proactive.

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[Case Study] FSP Insourcing – Relationship Growth Built on Results, Trust

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[POCKET GUIDE] 3 Steps To Supercharge Your Literature Search

Go from Search to Full-Text Scientific Papers in a Single Click!

[Whitepaper] How to Re-Design your Regulatory Capabilities

A top 20 pharma and growing biotech re-engineer regulatory processes.

[Whitepaper] The Future of Pharmacovigilance: Leveraging Technology and Automation

Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be!

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

[eLearning] BIOAVAILABILITY 101

Develop a basic understanding of principles and concepts of bioavailability of oral drugs.

Events

.